共 9 条
[1]
Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer[J] TeppeiMorikawa;DaichiMaeda;HarukiKume;YukioHomma;MasashiFukayama Histopathology 2010,
[2]
Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy[J] Hayato Fujita;Kenoki Ohuchida;Kazuhiro Mizumoto;Soichi Itaba;Tetsuhide Ito;Kohei Nakata;Jun Yu;Tadashi Kayashima;Ryota Souzaki;Tatsuro Tajiri;Tatsuya Manabe;Takao Ohtsuka;Masao Tanaka Neoplasia 2010,
[3]
Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas[J] Takao Itoi;Atsushi Sofuni;Noriyoshi Fukushima;Fumihide Itokawa;Takayoshi Tsuchiya;Toshio Kurihara;Fuminori Moriyasu;Akihiko Tsuchida;Kazuhiko Kasuya Journal of Gastroenterology 2007,
[4]
Ribonucleotide reductase and the regulation of DNA replication: an old story and an ancient heritage[J] JohnHerrick;BiancaSclavi Molecular Microbiology 2006,
[5]
Ribonucleotide reductase: an old target with new potential[J] B.Douglas Smith;Judith E. Karp Leukemia Research 2003,
[6]
Cellular signaling pathways affect the function of ribonucleotide reductasemRNA binding proteins: mRNA stabilization; drug resistance; and malignancy (Review)[J] Teralee Burton;Tarek Kashour;Jim Wright;Francis Amara International Journal of Oncology 2003,
[7]
DISSEMINATING THE GENOME: Joining; Resolving; and Separating Sister Chromatids During Mitosis and Meiosis[J] Kim Nasmyth Annual Review of Genetics 2001,
[8]
Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential[J] Bing-Sen Zhou;Pamela Tsai;Rhonda Ker;Jeffrey Tsai;Roger Ho;Johnathan Yu;Jennifer Shih;Yun Yen Clinical and Experimental Metastasis 1998,
[9]
Ribonucleotide reductase M2subunit is a novel marker and a potential therapeutic target for gastric carcinoma Morikawa T;Hino R;Uozaki H;et al; 2009,

